Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

Parkinson's may be due to environmental causes. One million people have the neurodegenerative disease that robs them of their ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Researchers believe a usually harmless virus could trigger Parkinson’s disease. The Human Pegivirus (HPgV) belongs to the ...

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Scientists find volatile compounds in ear wax may help detect Parkinson's disease earlier than traditional methods, offering ...

针对帕金森病（PD）患者跌倒风险与认知障碍共病难题，研究者开展TAK-071（M1受体正向变构调节剂）的II期随机对照试验。结果显示该药物虽未改善步态变异（p=0.6），但显著提升认知评分，安全性良好（胃肠道不良反应率=7.4%）。为胆碱能靶向治疗PD非运动症状提供新证据。